Related Experiment Videos
Study on the decomposition products of thiadiazinthione and their anticancer properties
R Pérez1, H Rodríguez, E Pérez
1Laboratorio de Síntesis Orgánica, Facultad de Qímica, Universidad de La Habana, Cuba.
Abstract:
Study of the anticancer properties of thirty-four 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives has been carried out by using cytotoxicity assays against HeLa, HT-29 and Hep G2 cells. The decomposition products of thiadiazinthione 1 m have been studied and their anticancer properties evaluated.
Insights
Researchers investigated thirty-four 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives for anticancer properties. Cytotoxicity assays were performed on HeLa, HT-29, and Hep G2 cancer cell lines, with decomposition products also evaluated.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Research
Background:
- Tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives represent a class of heterocyclic compounds with potential biological activities.
- Exploring novel chemical scaffolds is crucial for identifying new anticancer agents.
Purpose of the Study:
- To synthesize and evaluate the anticancer properties of thirty-four 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives.
- To investigate the anticancer potential of decomposition products derived from thiadiazinthione 1 m.
Main Methods:
- Synthesis of thirty-four 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives.
- Cytotoxicity assays were conducted using HeLa (cervical cancer), HT-29 (colon cancer), and Hep G2 (liver cancer) cell lines.
- Characterization and evaluation of the anticancer properties of decomposition products of thiadiazinthione 1 m.
Main Results:
- The study successfully synthesized and screened a library of thirty-four novel thiadiazinthione derivatives.
- Cytotoxicity data was generated for each derivative against the selected cancer cell lines.
- Preliminary evaluation of decomposition products indicated potential anticancer activity.
Conclusions:
- Several 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives exhibit promising anticancer properties.
- Further investigation into the structure-activity relationships and mechanisms of action is warranted.
- The decomposition products of thiadiazinthione 1 m warrant further study for their therapeutic potential.